Inactive Instrument

Heat Biologics Inc Stock Nasdaq

Equities

US42237K1025

Pharmaceuticals

Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
Sales 2022 6.38M 8.72M Sales 2023 6.99M 9.56M Capitalization 11.48M 15.69M
Net income 2022 -43M -58.76M Net income 2023 -45M -61.49M EV / Sales 2022 -2.23 x
Net cash position 2022 34.88M 47.66M Net Debt 2023 11.65M 15.92M EV / Sales 2023 3.31 x
P/E ratio 2022
-0.47 x
P/E ratio 2023
-0.25 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 96.28%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 60 08-06-09
Director of Finance/CFO 56 19-09-24
Investor Relations Contact - -
Members of the board TitleAgeSince
Director/Board Member 70 16-04-25
Chief Executive Officer 60 08-06-09
Director/Board Member 48 08-12-31
More insiders
Scorpius Holdings, Inc., formerly NightHawk Biosciences, Inc., is an integrated contract development and manufacturing company. The Company is focused on advancing biologic and cell therapy programs to the clinic and beyond. It offers a broad array of analytical testing, process development, and manufacturing services to pharmaceutical and biotech companies at its facilities in San Antonio, Texas. Its analytical services include development of a comprehensive range of analytical test methods to characterize complex biologics, including cell therapy-based products, protein therapeutics, vaccines and advanced therapies. Its Clinical Biomanufacturing includes cGMP Mammalian Cell Culture, and cGMP Microbial Fermentation. Its San Antonio facility is focused on the commercial-scale manufacturing of biodefense-focused molecules and biologics therapeutics. Its biomanufacturing services focus on accelerating product development timelines from pre-clinical evaluation to first-in-human studies.
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW